Search - tctmd.com

Displaying 421 - 440 of 560

Sort: Relevancy | Date

News Conference News ESC 2014

MITOCARE: Novel Drug as Adjunct to PCI for STEMI Does Not Reduce Reperfusion Injury Risk

Yael L. Maxwell

September 02, 2014

News Daily News

HORIZONS-AMI Substudy: Anticoagulation After Primary PCI Yields Worse Outcomes

September 02, 2014

News Conference News ESC 2014

NOMI: Nitric Oxide May Do Wonders for STEMI But Not When Mixed with Nitroglycerin

Caitlin E. Cox

September 01, 2014

News Conference News ESC 2014

SOLID-TIMI 52: Darapladib Fails to Reduce Adverse Events After ACS

Yael L. Maxwell

August 31, 2014

News Daily News

Similar Overall Long-Term Outcomes, Less Stent Thrombosis with Newer DES in STEMI

Todd Neale

August 22, 2014

News Daily News

In-Hospital Switching of Antiplatelet Agents in MI Patients Relatively Common, Driven by Patient Risk, Other Factors

L.A. McKeown

August 20, 2014

News Daily News

El Umbral de Troponina T Cardíaca Predice la Mortalidad Post-PCI

August 20, 2014

News Daily News

Cardiac Troponin T Threshold Predicts Mortality After PCI

August 20, 2014

News Daily News

Transradial PCI May Improve Long-term Survival in NSTEMI

Todd Neale

July 17, 2014

News Daily News

Las PCI Transradiales Podrían Mejorar la Supervivencia a Largo Plazo en los Cuadros de STEMI

Todd Neale

July 17, 2014

News Daily News

HEAT-PPCI Published: Discrepant Finding of Heparin’s Superiority over Bivalirudin in Primary PCI Still Puzzles

Yael L. Maxwell

July 17, 2014

News Daily News

HEAT-PPCI Publicado: El Discrepante Hallazgo de la Superioridad de la Heparina sobre la Bivalirudina en PCI Primarias Sigue Confundiendo

Yael L. Maxwell

July 17, 2014

News Daily News

Mesh-Covered Stent Safe in STEMI Patients but Risk of TLR, TVR Higher vs BMS

July 08, 2014

News Daily News

SCAAR: Menor Riesgo de Trombosis Precoz, Tardía del Stent con Nuevos SLF frente a SMD en el Manejo de Cuadros de STEMI

Yael L. Maxwell

July 03, 2014

News Daily News

SCAAR: Lower Risk of Early, Late Stent Thrombosis with Newer DES vs BMS in STEMI

Yael L. Maxwell

July 03, 2014

News Daily News

Prasugrel Efficacy in STEMI Largely Unaffected by PCI Timing

Yael L. Maxwell

June 17, 2014

News Daily News

BRAVE 4: Prasugrel Plus Bivalirudin Fails to Mitigate Stent Thrombosis in STEMI Patients

May 14, 2014

News Daily News

High Prasugrel Loading Dose Limits Platelet Reactivity after Primary PCI for STEMI

Caitlin E. Cox

April 09, 2014

News Daily News

Meta-analysis: Bone Marrow Mononuclear Cell Therapy Fails to Show Efficacy in Acute MI

Yael L. Maxwell

April 08, 2014

News Daily News

Registro FAST-MI: La Fibrinolisis y la PCI, Primaria arrojan una Supervivencia Similar a los 5 Años en Pacientes STEMI

L.A. McKeown

April 03, 2014

Advertisement

MITOCARE: Novel Drug as Adjunct to PCI for STEMI Does Not Reduce Reperfusion Injury Risk

HORIZONS-AMI Substudy: Anticoagulation After Primary PCI Yields Worse Outcomes

NOMI: Nitric Oxide May Do Wonders for STEMI But Not When Mixed with Nitroglycerin

SOLID-TIMI 52: Darapladib Fails to Reduce Adverse Events After ACS

Similar Overall Long-Term Outcomes, Less Stent Thrombosis with Newer DES in STEMI

In-Hospital Switching of Antiplatelet Agents in MI Patients Relatively Common, Driven by Patient Risk, Other Factors

El Umbral de Troponina T Cardíaca Predice la Mortalidad Post-PCI

Cardiac Troponin T Threshold Predicts Mortality After PCI

Transradial PCI May Improve Long-term Survival in NSTEMI

Las PCI Transradiales Podrían Mejorar la Supervivencia a Largo Plazo en los Cuadros de STEMI

HEAT-PPCI Published: Discrepant Finding of Heparin’s Superiority over Bivalirudin in Primary PCI Still Puzzles

HEAT-PPCI Publicado: El Discrepante Hallazgo de la Superioridad de la Heparina sobre la Bivalirudina en PCI Primarias Sigue Confundiendo

Mesh-Covered Stent Safe in STEMI Patients but Risk of TLR, TVR Higher vs BMS

SCAAR: Menor Riesgo de Trombosis Precoz, Tardía del Stent con Nuevos SLF frente a SMD en el Manejo de Cuadros de STEMI

SCAAR: Lower Risk of Early, Late Stent Thrombosis with Newer DES vs BMS in STEMI

Prasugrel Efficacy in STEMI Largely Unaffected by PCI Timing

BRAVE 4: Prasugrel Plus Bivalirudin Fails to Mitigate Stent Thrombosis in STEMI Patients

High Prasugrel Loading Dose Limits Platelet Reactivity after Primary PCI for STEMI

Meta-analysis: Bone Marrow Mononuclear Cell Therapy Fails to Show Efficacy in Acute MI

Registro FAST-MI: La Fibrinolisis y la PCI, Primaria arrojan una Supervivencia Similar a los 5 Años en Pacientes STEMI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content